Bionano Genomics Inc
BNGO3.040USD
+0.090+3.05%
交易中 （美东）报价延迟15分钟
9.43M总市值
亏损市盈率 TTM
关于 Bionano Genomics Inc 公司
Bionano Genomics, Inc. 是一家基因组学公司。该公司提供光学基因组图谱 (OGM) 解决方案，适用于基础研究、转化研究和临床研究。通过 Lineagen, Inc.，该公司还为临床表现与自闭症谱系障碍和其他神经发育障碍一致的患者提供诊断测试。它还提供与平台无关的软件解决方案，该解决方案集成了测序和微阵列数据，旨在通过一个综合视图提供对整个基因组的拷贝数变异、单核苷酸变异和杂合性缺失的分析、可视化、解释和报告。该公司还使用专有的等速电泳 (ITP) 技术提供核酸提取和纯化解决方案。该公司营销和销售 OGM 系统，包括 Saphyr 系统，该系统提供 OGM 数据，以实现对所有类别的结构变异 (SV) 的超灵敏和超特异性检测。
公司简介
公司代码BNGO
公司名称Bionano Genomics Inc
上市日期Aug 01, 2018
CEODr. R. Erik Holmlin, Ph.D.
员工数量98
证券类型Ordinary Share
年结日Aug 01
公司地址9540 Towne Centre Drive
城市SAN DIEGO
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编92121
电话18588887600
网址https://bionano.com/
公司代码BNGO
上市日期Aug 01, 2018
CEODr. R. Erik Holmlin, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
441.00
-5.77%
Mark Adamchak
Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Mr. David Holmes
Mr. David Holmes
Investor Relations Officer
Investor Relations Officer
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
441.00
-5.77%
Mark Adamchak
Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
业务USD
名称
营收
占比
Consumables
3.25M
50.29%
Software
2.07M
32.03%
Instruments
689.00K
10.67%
Services and other
453.00K
7.02%
地区USD
名称
营收
占比
EMEIA
3.07M
47.48%
Americas
3.06M
47.36%
Asia Pacific
333.00K
5.16%
业务
地区
业务USD
名称
营收
占比
Consumables
3.25M
50.29%
Software
2.07M
32.03%
Instruments
689.00K
10.67%
Services and other
453.00K
7.02%
股东统计
更新时间: 7月24日 周四
更新时间: 7月24日 周四
持股股东
股东类型
持股股东
持股股东
占比
Heights Capital Management, Inc.
4.69%
The Vanguard Group, Inc.
1.49%
Everstar Asset Management LLC
1.34%
GSA Capital Partners LLP
1.19%
Geode Capital Management, L.L.C.
0.46%
Other
90.83%
持股股东
持股股东
占比
Heights Capital Management, Inc.
4.69%
The Vanguard Group, Inc.
1.49%
Everstar Asset Management LLC
1.34%
GSA Capital Partners LLP
1.19%
Geode Capital Management, L.L.C.
0.46%
Other
90.83%
股东类型
持股股东
占比
Investment Advisor
8.32%
Hedge Fund
1.19%
Investment Advisor/Hedge Fund
0.47%
Research Firm
0.33%
Individual Investor
0.06%
Bank and Trust
0.02%
Other
89.62%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
193
349.15K
10.38%
-67.10K
2025Q1
262
309.73K
9.24%
-123.47K
2024Q4
284
105.26K
3.91%
-124.97K
2024Q3
298
94.17K
6.55%
-135.04K
2024Q2
310
116.15K
9.81%
-164.95K
2024Q1
318
86.19K
9.42%
-64.99K
2023Q4
324
107.44K
14.24%
-23.70K
2023Q3
345
94.81K
16.11%
-27.58K
2023Q2
356
93.86K
18.29%
-63.50K
2023Q1
366
141.65K
27.72%
-15.82K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Heights Capital Management, Inc.
157.93K
4.69%
-20.40K
-11.44%
Mar 31, 2025
The Vanguard Group, Inc.
49.98K
1.49%
+18.64K
+59.50%
Mar 31, 2025
Everstar Asset Management LLC
44.98K
1.34%
+44.98K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
15.51K
0.46%
-1.12K
-6.75%
Mar 31, 2025
Parametric Portfolio Associates LLC
11.49K
0.34%
+11.49K
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
10.10K
0.3%
-4.00
-0.04%
Mar 31, 2025
BofA Global Research (US)
8.39K
0.25%
+8.37K
+41865.00%
Mar 31, 2025
Osaic Holdings, Inc.
3.21K
0.1%
+3.03K
+1722.73%
Mar 31, 2025
UBS Financial Services, Inc.
1.91K
0.06%
-22.00
-1.14%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Dimensional US Core Equity 1 ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
SPDR S&P Kensho New Economies Composite ETF
0%
Global X Genomics & Biotechnology ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Genomics Immunology and Healthcare ETF
0%
Global X HealthTech ETF
0%
Dimensional US Core Equity 1 ETF
占比0%
Invesco NASDAQ Future Gen 200 ETF
占比0%
SPDR S&P Kensho New Economies Composite ETF
占比0%
Global X Genomics & Biotechnology ETF
占比0%
Invesco RAFI US 1500 Small-Mid ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%
iShares Genomics Immunology and Healthcare ETF
占比0%
Global X HealthTech ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
公告日期
类型
比率
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Jan 22, 2025
Merger
60<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
Aug 04, 2023
Merger
10<1
